Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.89
+0.18 (1.54%)
Aug 21, 2026, 3:50 PM EDT - Market open
Kura Oncology Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Kura Oncology stock has a consensus rating of "Strong Buy" and an average price target of $32. The average 1-year stock price forecast is 169.13% higher than the current stock price, while the lowest is $15 (+26.16%) and the highest is $76 (+539.19%).
Price Target: $32 (+169.13%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Kura Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 | 12 | 12 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $15 | Buy | Maintains | $15 | +26.16% | Aug 21, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
| Lake Street | Lake Street | Buy Reiterates $23 | Buy | Reiterates | $23 | +93.44% | Aug 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $31 | Buy | Reiterates | $31 | +160.72% | Aug 13, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $28 | Buy | Maintains | $28 | +135.49% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
100.01M
from 67.48M
Increased by 48.20%
Revenue Next Year
214.98M
from 100.01M
Increased by 114.96%
EPS This Year
-3.23
from -3.18
EPS Next Year
-2.30
from -3.23
EPS and Forward PE are based on non-GAAP adjusted numbers.